Method of producing a recombinant non-glycosylated gp90 of equine infectious anemia virus (EIAV), and product thereof
AssigneeUniversidade Federal De Minas Gerais - Ufmg
InventorsPaulo C. P. Ferreira, Erna G. Kroon, Jenner K. P. Dos Reis, Isabella B. F. Ferraz, Romulo C. Leite
Life of this patent
Estimating the term…
Abstract
The present invention describes recombinant gp90 envelop protein derived from the equine infectious anemia virus, their corresponding encoding recombinant DNA molecule and the process of production of the recombinant protein produced through genetic engineering techniques, to be used in diagnosis, vaccination or in research.
Claims5
A process for producing the recombinant gp 90 Equine Infectious Anemia envelope protein consisting of an amino acid sequence of SEQ ID NO:
- 5 comprising culturing in E. coli cell under conditions whereby said protein is produced.
An amino acid sequence consisting of SEO ID NO:5 which is not glycosylated.
Dependencies are inferred from the claim text.